We are live on
!
Find out more
RCMNY
Rubric Capital Management (New York) Portfolio holdings
AUM
$9.44B
1-Year Est. Return
68.42%
This Fund
S&P 500
This Quarter
Est. Return
+8.45%
1 Year Est. Return
+68.42%
3 Year Est. Return
+212.09%
5 Year Est. Return
+270.59%
10 Year Est. Return
–
AUM
$8.36B
AUM Growth
-$501M
(-5.7%)
Cap. Flow
-$840M
Cap. Flow
% of AUM
-10.05%
Top 10 Holdings %
Top 10 Hldgs %
55.3%
Holding
88
New
16
Increased
20
Reduced
17
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vistra
VST
|
+$364M |
| 2 |
Constellation Energy
CEG
|
+$243M |
| 3 |
Viatris
VTRS
|
+$109M |
| 4 |
Akamai
AKAM
|
+$98.7M |
| 5 |
PRMB
Primo Brands
PRMB
|
+$67.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Roivant Sciences
ROIV
|
+$217M |
| 2 |
Baxter International
BAX
|
+$86M |
| 3 |
Teva Pharmaceuticals
TEVA
|
+$81.2M |
| 4 |
Arcutis Biotherapeutics
ARQT
|
+$63.4M |
| 5 |
Collegium Pharmaceutical
COLL
|
+$55.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 33.3% |
| 2 | Utilities | 26.27% |
| 3 | Industrials | 14.79% |
| 4 | Energy | 5.36% |
| 5 | Financials | 4.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Alight
ALIT
$377M
| – | – |
-569,929
| Closed | -$37.2M |
|
77
ANI Pharmaceuticals
ANIP
$1.73B
| – | – |
-343,414
| Closed | -$31.5M |
|
|
78
Baxter International
BAX
$13.9B
| – | – |
-3,774,889
| Closed | -$86M |
|
79
Cannae Holdings
CNNE
$651M
| – | – |
-1,319,589
| Closed | -$24.2M |
|
|
DAWN
80
DELISTED
Day One Biopharmaceuticals
DAWN
| – | – |
-3,377,071
| Closed | -$23.8M |
|
81
PUT
iShares Russell 2000 ETF
IWM
$82.2B
| – | – |
-2,000,000
| Closed | -$484M |
|
82
Mohawk Industries
MHK
$9.27B
| – | – |
-85,726
| Closed | -$11.1M |
|
|
SCPH
83
DELISTED
scPharmaceuticals
SCPH
| – | – |
-5,101,886
| Closed | -$28.9M |
|
84
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$809B
| – | – |
-1,400,000
| Closed | -$933M |
|
85
Supernus Pharmaceuticals
SUPN
$2.78B
| – | – |
-595,366
| Closed | -$28.5M |
|
|
THS
86
DELISTED
Treehouse Foods
THS
| – | – |
-70,372
| Closed | -$1.42M |
|
87
TETRA Technologies
TTI
$1.29B
| – | – |
-4,529,783
| Closed | -$26M |
|
Similar funds
RCM
SIM
NPT
AC
PVI
WPL
LAMI
CCMT
Rubric Capital Management (New York)'s Q4 2025 Portfolio in Review
As of Q4 2025, Rubric Capital Management (New York) held 88 positions worth $8.36B, down 5.7% from $8.86B the previous quarter. Its ten largest holdings account for 55% of the portfolio.
Rubric Capital Management (New York) withdrew a net $840M in Q4 2025, closing 12 positions and reducing 17 holdings. Its most notable exit was Baxter International, an estimated $86M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 31% a quarter earlier, followed by Utilities and Industrials.
Against the trend, Rubric Capital Management (New York) opened a new position in Vistra worth $323M.
- Rubric Capital Management (New York)'s largest Q4 2025 buy was Vistra: 2,000,000 shares worth $323M.
- Rubric Capital Management (New York) added most to Viatris in Q4 2025, an estimated $109M increase.
- Rubric Capital Management (New York)'s biggest Q4 2025 reduction was Roivant Sciences, cutting an estimated $217M.
- Rubric Capital Management (New York) fully exited Baxter International in Q4 2025, selling an estimated $86M.
- Rubric Capital Management (New York)'s ten largest holdings make up 55% of its $8.36B portfolio in Q4 2025.
- Rubric Capital Management (New York) opened 16 new positions and closed 12 in Q4 2025.
- Rubric Capital Management (New York)'s portfolio value fell 5.7% quarter-over-quarter to $8.36B.
Based on Rubric Capital Management (New York)'s 13F filing for Q4 2025, filed 13 Feb 2026.